Cargando…
Fulminant Reversible Cerebral Vasoconstriction Syndrome in Breakthrough COVID 19 Infection
COVID 19 infection continues to afflict people worldwide. Neurological complications of COVID infection are common. We report a case of fulminant reversible cerebrovascular constriction syndrome (RCVS) in a patient with breakthrough COVID 19 infection who was fully vaccinated. A 64 year old lady, fu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616734/ https://www.ncbi.nlm.nih.gov/pubmed/34915308 http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.106238 |
_version_ | 1784604409181765632 |
---|---|
author | Ray, Somdattaa Kamath, Vikram V. Raju P, Arjun KN, Rajesh N, Shalini |
author_facet | Ray, Somdattaa Kamath, Vikram V. Raju P, Arjun KN, Rajesh N, Shalini |
author_sort | Ray, Somdattaa |
collection | PubMed |
description | COVID 19 infection continues to afflict people worldwide. Neurological complications of COVID infection are common. We report a case of fulminant reversible cerebrovascular constriction syndrome (RCVS) in a patient with breakthrough COVID 19 infection who was fully vaccinated. A 64 year old lady, fully vaccinated 2 months back, presented with headache, drowsiness, partial seizures, visual impairment and quadriplegia. Her nasopharyngeal swab was tested positive for SARS COV2 on real time PCR assay. MRI brain FLAIR images showed multifocal hyperintensities with MR angiogram showing arterial vasoconstriction suggestive of RCVS. Despite initiation of nimodipine, patient's symptoms worsened and she succumbed to sepsis. RCVS following COVID infection has been reported to have a benign outcome. However, despite vaccination, fulminant RCVS following a breakthrough COVID infection was observed in our patient. |
format | Online Article Text |
id | pubmed-8616734 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86167342021-11-26 Fulminant Reversible Cerebral Vasoconstriction Syndrome in Breakthrough COVID 19 Infection Ray, Somdattaa Kamath, Vikram V. Raju P, Arjun KN, Rajesh N, Shalini J Stroke Cerebrovasc Dis Case Report COVID 19 infection continues to afflict people worldwide. Neurological complications of COVID infection are common. We report a case of fulminant reversible cerebrovascular constriction syndrome (RCVS) in a patient with breakthrough COVID 19 infection who was fully vaccinated. A 64 year old lady, fully vaccinated 2 months back, presented with headache, drowsiness, partial seizures, visual impairment and quadriplegia. Her nasopharyngeal swab was tested positive for SARS COV2 on real time PCR assay. MRI brain FLAIR images showed multifocal hyperintensities with MR angiogram showing arterial vasoconstriction suggestive of RCVS. Despite initiation of nimodipine, patient's symptoms worsened and she succumbed to sepsis. RCVS following COVID infection has been reported to have a benign outcome. However, despite vaccination, fulminant RCVS following a breakthrough COVID infection was observed in our patient. Elsevier Inc. 2022-02 2021-11-26 /pmc/articles/PMC8616734/ /pubmed/34915308 http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.106238 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Case Report Ray, Somdattaa Kamath, Vikram V. Raju P, Arjun KN, Rajesh N, Shalini Fulminant Reversible Cerebral Vasoconstriction Syndrome in Breakthrough COVID 19 Infection |
title | Fulminant Reversible Cerebral Vasoconstriction Syndrome in Breakthrough COVID 19 Infection |
title_full | Fulminant Reversible Cerebral Vasoconstriction Syndrome in Breakthrough COVID 19 Infection |
title_fullStr | Fulminant Reversible Cerebral Vasoconstriction Syndrome in Breakthrough COVID 19 Infection |
title_full_unstemmed | Fulminant Reversible Cerebral Vasoconstriction Syndrome in Breakthrough COVID 19 Infection |
title_short | Fulminant Reversible Cerebral Vasoconstriction Syndrome in Breakthrough COVID 19 Infection |
title_sort | fulminant reversible cerebral vasoconstriction syndrome in breakthrough covid 19 infection |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616734/ https://www.ncbi.nlm.nih.gov/pubmed/34915308 http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.106238 |
work_keys_str_mv | AT raysomdattaa fulminantreversiblecerebralvasoconstrictionsyndromeinbreakthroughcovid19infection AT kamathvikramv fulminantreversiblecerebralvasoconstrictionsyndromeinbreakthroughcovid19infection AT rajuparjun fulminantreversiblecerebralvasoconstrictionsyndromeinbreakthroughcovid19infection AT knrajesh fulminantreversiblecerebralvasoconstrictionsyndromeinbreakthroughcovid19infection AT nshalini fulminantreversiblecerebralvasoconstrictionsyndromeinbreakthroughcovid19infection |